Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methazolamide versus acetazolamide for prevention of acute mountain sickness
ChiCTR2400089203Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methazolamide and acetazolamide in acute mountain sickness (AMS) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Occurrence of acute mountain sickness, Occurrence of high-altitude pulmonary edema and 2 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
methazolamideacetazolamide
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on ChiCTR2400089203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089203.